Purchase Order 75N98024P01968

Award Date 6/25/24
Potential Completion Date 8/24/24
Potential Value $143K
Funding Federal Agency
National Eye Institute
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of genetic analysis and sequencing instruments and reagents. The $38,900.48 contract is to provide various Illumina sequencing systems, consumables, and support services to support genomic research and diagnostics. The order was awarded under a standing purchase quote, and there was...
This $118,914.05 firm-fixed-price delivery order was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute on Aging to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH, CDC, USDA, and VA to provide sequencing platforms, reagents, and related bioinformatics support...
Illumina, Inc., a for-profit manufacturer of genomic analysis equipment and reagents, was awarded a $146,645.78 firm fixed price delivery order contract by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract is for the provision of 24 INFINIUM EXOME-24 V1.1 KIT (48 SAMPLES) units at a unit price of $2,272.50, with a completion date of September 2, 2025. The contract does not have a set-aside designation. Illumina has...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $249,229.80 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analytical instruments and reagents. The contract is for the provision of Illumina's sequencing systems, reagents, and associated products and services to support genomic research and diagnostics. This award...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of gene sequencing systems and reagents. The $105,412.33 contract is for the provision of Illumina's sequencing instruments, consumables, and maintenance services to support genomic analysis and research at the agency. This award does not have any set-aside designation. Illumina has a...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the provision of Illumina reagents and consumables. The potential value of the contract is $104,951.00, with a completion date of September 30, 2021. This award does not utilize any set-aside designation. Illumina has previously received prime federal...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a $177,279.90 firm fixed-price delivery order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The order is for Illumina reagents and consumables to support the agency's research and diagnostic needs. Illumina has previously been awarded prime federal contracts by agencies such as the NIH, Centers for...
The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price delivery order contract valued at $121,353.93 to Illumina, Inc., a for-profit manufacturing company, to provide sequencing and array-based genomic analysis solutions. The contract has a completion date of September 2, 2025 and does not include any set-aside provisions. Illumina has previously received awards from federal agencies such as the...
This is a firm fixed price delivery order issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, to Illumina, Inc. The $101,668.72 contract is for the provision of various Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of sequencing and array-based analytical instruments and reagents, has previously been...

The Department of Health and Human Services' National Institutes of Health National Eye Institute awarded a $142,810.50 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The award is for the provision of an analytical laboratory instrument, with a completion date of August 24, 2024. Illumina has been a prime contractor on numerous federal contracts across agencies like the NIH, CDC, USDA, and VA, primarily providing sequencing systems, reagents, and related services to support genomic research and diagnostics. While no set-aside designation is noted, Illumina has experience as a subcontractor to primes such as Triad National Security and Battelle Memorial Institute. The company also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery worth up to $3.3 million for nucleic acid sequencing supplies and instrumentation used in biological threat characterization.

Generated 6/6/24, 9:40 AM